Program at a Glance

Please Note: All session times for ICKSH 2022 are in Korea Standard Time (KST) UTC +9.
Room Room 1 Room 2 Room 3 Room 4
Date Saturday, April 2, 2022
07:30-08:30 Business Meeting
08:30-09:00 Working Party Reports
09:00-10:30 [AS02] Asian Hematology Session 2
(09:00-10:00)
- Pediatric ALL
[SS13] AML [SS14] Lymphoma (2) - T cell / HL [ES07] Supportive Care
Ma-Spore ALL studies: truly Asia approach to curing childhood ALL
Allen E.J. Yeoh, Singapore
AML microenvironment and FLT3 inhibitor resistance
Elie Traer, USA
Genomic landscape of peripheral T-cell lymphomas
Keisuke Kataoka, Japan
Comprehensive geriatric assessment in older patients for intensive chemotherapy
Jung-Yeon Choi, Korea
Childhood ALL in Thailand and multicenter studies of Thai pediatric oncology group
Samart Pakakasama, Thailand
Targeting TP53 mutation in AML
David A. Sallman, USA
T-cell lymphomas of follicular helper T-cell derivation: pathology, mechanisms and therapeutic implications
Laurence de Level, Switzerland
Evaluation and management of platelet transfusion refractoriness
Dae-Hyun Ko, Korea
The adherence to MRD time points improves treatment outcomes of childhood
ALL in Taiwan: the experience of TPOG-ALL-2013 protocol
Hsi-Che Liu, Taiwan
Adaptive immune resistance and immune evasion by programmed death-1 homolog (PD-1H/VISTA) in AML
Tae Kon Kim, US
Targeted therapy to small molecules in peripheral T cell lymphomas
Deok Hwan Yang, Korea
Advances in management of invasive fungal infections: perspectives on hematologic diseases
Dong-Gun Lee, Korea
10:30-11:15 Plenary Lecture III
Improving outcomes after CD19-targeted CAR T-cell therapy
Jordan Gauthier, USA
11:15-11:30 Break
11:30-12:10 Award Ceremony & Closing
Organized by
Supported by

Sponsored by